MAGOMEGA
LIVE

Serial Number

79349088

Owner

SOLUTEX GC

Attorney

Todd A. Sullivan

Filing Date

Jul 6, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MAGOMEGA Trademark

Serial Number: 79349088 • Registration: 7209612

MAGOMEGA is a trademark filed by SOLUTEX GC on July 6, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SOLUTEX GC (11 trademarks)

Avenida de la Transición Española,
Alcobendas E-28108 , ES

Entity Type: 16

Trademark Details

Filing Date

July 6, 2022

Registration Date

November 7, 2023

Published for Opposition

August 22, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 4, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 9, 2024 FICS
FINAL DISPOSITION PROCESSED
Feb 9, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 7, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 7, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 7, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 22, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 22, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Aug 21, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 2, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 2, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 2, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 17, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 13, 2023 TROA
REFUSAL PROCESSED BY IB
Jul 4, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 11, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 11, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 29, 2023 RFCR
NON-FINAL ACTION WRITTEN
Apr 28, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 20, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 13, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 8, 2022 REPR